Literature DB >> 16863906

Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone.

Ingrid G Winkler1, Jean-Pierre Lévesque.   

Abstract

Mobilization is now used worldwide to collect large numbers of hematopoietic stem and progenitor cells (HSPCs) for transplantation. Although the first mobilizing agents were discovered largely by accident, discovery of more efficient mobilizing agents will require a better understanding of the molecular mechanisms responsible. During the past 5 years, a number of mechanisms have been identified, shedding new light on the dynamics of the hematopoietic system in vivo and on the intricate relationship between hematopoiesis, innate immunity, and bone. After briefly reviewing the mechanisms by which circulating HSPCs home into the bone marrow and what keeps them there, the current knowledge of mechanisms responsible for HSPC mobilization in response to hematopoietic growth factors such as granulocyte colony-stimulating factor, chemotherapy, chemokines, and polyanions will be discussed together with current strategies developed to further increase HSPC mobilization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863906     DOI: 10.1016/j.exphem.2006.04.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  35 in total

1.  Poor Mobilization in T-Cell-Deficient Nude Mice Is Explained by Defective Activation of Granulocytes and Monocytes.

Authors:  Marcin Wysoczynski; Mateusz Adamiak; Malwina Suszynska; Ahmed Abdel-Latif; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Cell Transplant       Date:  2016-07-18       Impact factor: 4.064

2.  Stem cells on patrol.

Authors:  Robert S Welner; Paul W Kincade
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 3.  Neutrophil biology and the next generation of myeloid growth factors.

Authors:  David C Dale
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

4.  Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients.

Authors:  Barbara Skopec; Matevz Skerget; Darja Zontar; Vesna Zadnik; Samo Zver
Journal:  Wien Klin Wochenschr       Date:  2017-04-24       Impact factor: 1.704

5.  Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Hélène Lapillonne; Annelaure Leclerc; Tim Ulinski; Laurent Balu; Arnaud Garnier; Nathalie Dereuddre-Bosquet; Hervé Watier; Marie-Hélène Schlageter; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

6.  Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.

Authors:  Mohamed L Salem; Amir A Al-Khami; Sabry A El-Naggar; C Marcela Díaz-Montero; Yian Chen; David J Cole
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

Review 7.  Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Authors:  Joshua Tay; Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

8.  Cellular therapy for repair of cardiac damage after acute myocardial infarction.

Authors:  Matthew M Cook; Katarina Kollar; Gary P Brooke; Kerry Atkinson
Journal:  Int J Cell Biol       Date:  2009-03-29

9.  Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes.

Authors:  H M Lee; M Wysoczynski; R Liu; D-M Shin; M Kucia; M Botto; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-12-24       Impact factor: 11.528

10.  Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.

Authors:  H M Lee; W Wu; M Wysoczynski; R Liu; E K Zuba-Surma; M Kucia; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.